Therapeutic Cancer Vaccines

Research into the use of therapeutic vaccines to activate of the immune system in the treatment of cancer has increased significantly in recent years as part of the massive attention to other immuno oncology approaches.

A new report by Infiniti Research suggests they're here to stay and will begin taking off in a big way. Through 2019, cancer vaccines will see a CAGR of 27.24%, the report says, with the main growth drivers being an increased prevalence of cancer, a rising public awareness of vaccines, late-stage pipeline candidates, patient-assistance programs and most importantly the practice of pairing cancer vaccines with other therapies such as checkpoint inhibitors.


back to top